Download PDF
Clin Colon Rectal Surg 2016; 29(04): 296-305
DOI: 10.1055/s-0036-1584091
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Colonic Polyps: Diagnosis and Surveillance

Michael B. Huck
1   Department of General Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina
,
Jaime L. Bohl
1   Department of General Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina
› Author Affiliations
Further Information

Publication History

Publication Date:
21 November 2016 (online)

    Permissions and Reprints

Abstract

Colorectal cancer begins as a polyp that is a benign growth on the mucosal surface of the colon or rectum. Over a period of 5 to 15 years, polyps can degenerate into a cancer, thus invading the colonic wall. Colorectal screening methods are designed to diagnose and remove polyps before they acquire invasive potential and develop into cancer. Screening for colorectal cancer can prevent and reduce mortality. Given the benefits and effectiveness of screening, guidelines exist from multiple organizations. These guidelines risk-stratify patients to determine the age of screening initiation and the interval for repeat screening. Categories of colorectal cancer risk include average risk, increased risk, and high risk based on individual and family medical history. Screening methods vary widely in the ability to diagnose and treat polyps and in the degree of invasiveness or risk of complication to the patient. Colonoscopy is held as the “gold standard” by which all other methods are compared; however, less-invasive modalities including computed tomographic colonography are increasing in popularity.

Keywords

colorectal polyps - colonoscopy - colorectal screening - CT colonography
 

  • References

  • 1 Sarfaty M, Wender R. How to increase colorectal cancer screening rates in practice. CA Cancer J Clin 2007; 57 (6) 354-366
    CrossrefPubMedGoogle Scholar
  • 2 Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology 1987; 93 (5) 1009-1013
    CrossrefPubMedGoogle Scholar
  • 3 Winawer SJ, Zauber AG, Ho MN , et al; The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329 (27) 1977-1981
    CrossrefPubMedGoogle Scholar
  • 4 Sabatino SA, White MC, Thompson TD, Klabunde CN ; Centers for Disease Control and Prevention (CDC). Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64 (17) 464-468
    PubMedGoogle Scholar
  • 5 Levin B, Lieberman DA, McFarland B , et al; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134 (5) 1570-1595
    CrossrefPubMedGoogle Scholar
  • 6 Jackson-Thompson J, Ahmed F, German RR, Lai SM, Friedman C. J. J-T. Descriptive epidemiology of colorectal cancer in the United States, 1998-2001. Cancer 2006; 107 (5, Suppl): 1103-1111
    CrossrefPubMedGoogle Scholar
  • 7 Health O, Assessment T. Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses. Vol 9. 2009 . Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3377498&tool=pmcentrez&rendertype=abstract
    PubMedGoogle Scholar
  • 8 Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR ; United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143 (3) 844-857
    CrossrefPubMedGoogle Scholar
  • 9 Lautrup CK, Mikkelsen EM, Lash TL, Katballe N, Sunde L. Familial colorectal cancer risk may be lower than previously thought: a Danish cohort study. Cancer Epidemiol 2015; 39 (5) 714-719
    CrossrefPubMedGoogle Scholar
  • 10 Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006; 42 (2) 216-227
    CrossrefPubMedGoogle Scholar
  • 11 Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96 (10) 2992-3003
    CrossrefPubMedGoogle Scholar
  • 12 Freedman AN, Slattery ML, Ballard-Barbash R , et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol 2009; 27 (5) 686-693
    CrossrefPubMedGoogle Scholar
  • 13 Park Y, Freedman AN, Gail MH , et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol 2009; 27 (5) 694-698
    CrossrefPubMedGoogle Scholar
  • 14 Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW ; American College of Gastroenterology. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015; 110 (2) 223-262 , quiz 263
    CrossrefPubMedGoogle Scholar
  • 15 Knudsen AL, Bisgaard ML, Bülow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003; 2 (1) 43-55
    CrossrefPubMedGoogle Scholar
  • 16 Burt RW, Leppert MF, Slattery ML , et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 2004; 127 (2) 444-451
    CrossrefPubMedGoogle Scholar
  • 17 Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology 2010; 138 (6) 2044-2058
    CrossrefPubMedGoogle Scholar
  • 18 Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994–1634 14 (4B) 1631-1634
    PubMedGoogle Scholar
  • 19 Beggs AD, Latchford AR, Vasen HF , et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 2010; 59 (7) 975
    CrossrefPubMedGoogle Scholar
  • 20 Giardiello FM, Trimbath JD. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 2006; 4 (4) 408
    CrossrefPubMedGoogle Scholar
  • 21 Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005; 100 (2) 476
    CrossrefPubMedGoogle Scholar
  • 22 Gammon A, Jasperson K, Kohlmann W, Burt RW. Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol 2009; 23 (2) 219
    CrossrefPubMedGoogle Scholar
  • 23 Hearle N, Schumacher V, Menko FH , et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006; 12 (10) 3209
    CrossrefPubMedGoogle Scholar
  • 24 van Lier MGF, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 2010; 105 (6) 1258-1264 , author reply 12655
    CrossrefPubMedGoogle Scholar
  • 25 Giardiello FM, Brensinger JD, Tersmette AC , et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119 (6) 1447-1453
    CrossrefPubMedGoogle Scholar
  • 26 Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 1999; 55 (5) 735-750
    CrossrefPubMedGoogle Scholar
  • 27 Dunlop M. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002 ;(1). Available at: http://gut.bmj.com/content/51/suppl_5/v21.extract
    PubMedGoogle Scholar
  • 28 Latchford AR, Neale K, Phillips RK, Clark SK. Juvenile polyposis syndrome: a study of genotype, phenotype, and long-term outcome. Dis Colon Rectum 2012; 55 (10) 1038-1043
    CrossrefPubMedGoogle Scholar
  • 29 Brosens LA, van Hattem A, Hylind LM , et al. Risk of colorectal cancer in juvenile polyposis. Gut 2007; 56 (7) 965-967
    CrossrefPubMedGoogle Scholar
  • 30 Stanich PP, Owens VL, Sweetser S , et al. Colonic polyposis and neoplasia in Cowden syndrome. Mayo Clin Proc 2011; 86 (6) 489-492
    CrossrefPubMedGoogle Scholar
  • 31 Tan M-H, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012; 18 (2) 400-407
    CrossrefPubMedGoogle Scholar
  • 32 Riegert-Johnson DL, Gleeson FC, Roberts M , et al. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract 2010; 8 (1) 6
    CrossrefPubMedGoogle Scholar
  • 33 Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48 (4) 526-535
    CrossrefPubMedGoogle Scholar
  • 34 Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (London, England): 1990 336. (8711) 357-359 . Available at: http://www.ncbi.nlm.nih.gov/pubmed/1975343
    PubMedGoogle Scholar
  • 35 Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 23 (8) 1097-1104
    CrossrefPubMedGoogle Scholar
  • 36 Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 149 (9) 638-658
    CrossrefPubMedGoogle Scholar
  • 37 Howlader N, Noone A, Krapcho M , et al. SEER Cancer Statistics Review, 1975–2011. Natl Cancer Inst. 2014: based on November 2013 SEER data submission, poste. Available at: http://seer.cancer.gov/csr/1975_2011/
    PubMedGoogle Scholar
  • 38 Collins PD. Strategies for detecting colon cancer and dysplasia in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19 (4) 860-863
    CrossrefPubMedGoogle Scholar
  • 39 Collins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006; (2) CD000279
    PubMedGoogle Scholar
  • 40 Robertson DJ, Kaminski MF, Bretthauer M. Effectiveness, training and quality assurance of colonoscopy screening for colorectal cancer. Gut 2015; 64 (6) 982-990
    CrossrefPubMedGoogle Scholar
  • 41 Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev 2012; 21 (3) 411-416
    CrossrefPubMedGoogle Scholar
  • 42 Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014; 348 (April) g2467
    CrossrefPubMedGoogle Scholar
  • 43 Rex DK, Cutler CS, Lemmel GT , et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112 (1) 24-28
    CrossrefPubMedGoogle Scholar
  • 44 Ahn SB, Han DS, Bae JH, Byun TJ, Kim JP, Eun CS. The miss rate for colorectal adenoma determined by quality-adjusted, back-to-back colonoscopies. Gut Liver 2012; 6 (1) 64-70
    CrossrefPubMedGoogle Scholar
  • 45 Tanaka S, Kaltenbach T, Chayama K, Soetikno R. High-magnification colonoscopy (with videos). Gastrointest Endosc 2006; 64 (4) 604-613
    CrossrefPubMedGoogle Scholar
  • 46 Rex DK. Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc 2000; 51 (1) 33-36
    CrossrefPubMedGoogle Scholar
  • 47 Hüneburg R, Lammert F, Rabe C , et al. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy 2009; 41 (4) 316-322
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Itzkowitz SH, Present DH ; Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11 (3) 314-321
    CrossrefPubMedGoogle Scholar
  • 49 Marion JF, Waye JD, Present DH , et al; Chromoendoscopy Study Group at Mount Sinai School of Medicine. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008; 103 (9) 2342-2349
    CrossrefPubMedGoogle Scholar
  • 50 Anderson ML, Pasha TM, Leighton JA. Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol 2000; 95 (12) 3418-3422
    CrossrefPubMedGoogle Scholar
  • 51 Segnan N, Senore C, Andreoni B , et al; SCORE3 Working Group-Italy. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007; 132 (7) 2304-2312
    CrossrefPubMedGoogle Scholar
  • 52 Levin B, Lieberman DA, McFarland B , et al; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58 (3) 130-160
    CrossrefPubMedGoogle Scholar
  • 53 Schoen RE, Pinsky PF, Weissfeld JL , et al; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366 (25) 2345-2357
    CrossrefPubMedGoogle Scholar
  • 54 Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2012; 9 (12) e1001352
    CrossrefPubMedGoogle Scholar
  • 55 Lilly E. According To the Distal Colorectal Findings. Risk Adv Prox Neoplasms Adults Accord To Distal Color Find. 2000 343. (3) 169-174 . Available at: http://www.nejm.org/doi/pdf/10.1056/NEJM200007203430302
    PubMedGoogle Scholar
  • 56 Knight JR, Kanotra S, Siameh S, Jones J, Thompson B, Thomas-Cox S. Understanding barriers to colorectal cancer screening in Kentucky. Prev Chronic Dis 2015; 12: E95
    PubMedGoogle Scholar
  • 57 May FP, Whitman CB, Varlyguina K, Bromley EG, Spiegel BMR. Addressing low colorectal cancer screening in African Americans: using focus groups to inform the development of effective interventions. J Cancer Educ 2015; (May) : doi: 10.1007/s13187-015-0842-z
    PubMedGoogle Scholar
  • 58 Curbow BA, Dailey AB, King-Marshall EC , et al. Pathways to colonoscopy in the South: seeds of health disparities. Am J Public Health 2015; 105 (4) e103-e111
    PubMedGoogle Scholar
  • 59 Johnson CD, Chen M-H, Toledano AY , et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008; 359 (12) 1207-1217
    CrossrefPubMedGoogle Scholar
  • 60 Pickhardt PJ, Choi JR, Hwang I , et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349 (23) 2191-2200
    CrossrefPubMedGoogle Scholar
  • 61 Halligan S, Altman DG, Taylor SA , et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005; 237 (3) 893-904
    CrossrefPubMedGoogle Scholar
  • 62 Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med 2005; 142 (8) 635-650
    CrossrefPubMedGoogle Scholar
  • 63 Brenner DJ, Georgsson MA. Mass screening with CT colonography: should the radiation exposure be of concern?. Gastroenterology 2005; 129 (1) 328-337
    CrossrefPubMedGoogle Scholar
  • 64 Gluecker TM, Johnson CD, Wilson LA , et al. Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology 2003; 124 (4) 911-916
    CrossrefPubMedGoogle Scholar
  • 65 Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK Consultant Radiologists 1992 to 1994. Clin Radiol 1997; 52 (2) 142-148
    CrossrefPubMedGoogle Scholar
  • 66 Sosna J, Sella T, Sy O , et al. Critical analysis of the performance of double-contrast barium enema for detecting colorectal polyps > or = 6 mm in the era of CT colonography. AJR Am J Roentgenol 2008; 190 (2) 374-385
    CrossrefPubMedGoogle Scholar
  • 67 Halligan S, Wooldrage K, Dadswell E , et al; SIGGAR Investigators. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet 2013; 381 (9873) 1185-1193
    CrossrefPubMedGoogle Scholar
  • 68 Analysis AE. Fecal Occult Blood Test for Colorectal Cancer Screening: An Evidence-Based Analysis. Vol 9. 2009 . Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3377532&tool=pmcentrez&rendertype=abstract
    PubMedGoogle Scholar
  • 69 Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract. 4. (4) 150-156 . Available at: http://www.ncbi.nlm.nih.gov/pubmed/11525101
    PubMedGoogle Scholar
  • 70 Lieberman DA, Weiss DG ; Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345 (8) 555-560
    CrossrefPubMedGoogle Scholar
  • 71 Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol 2008; 103 (6) 1541-1549
    CrossrefPubMedGoogle Scholar
  • 72 Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334 (3) 155-159
    CrossrefPubMedGoogle Scholar
  • 73 Nadel MR, Shapiro JA, Klabunde CN , et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 2005; 142 (2) 86-94
    CrossrefPubMedGoogle Scholar
  • 74 Nakama H, Yamamoto M, Kamijo N , et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology. 46. 25 228-231 . Available at: http://www.ncbi.nlm.nih.gov/pubmed/10228797
    PubMedGoogle Scholar
  • 75 Health Quality Ontario. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Ont Health Technol Assess Ser 2009; 9 (10) 1-40
    PubMedGoogle Scholar
  • 76 Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME ; Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351 (26) 2704-2714
    CrossrefPubMedGoogle Scholar